Vimarsana
Biggest News Aggregation in the World

Kingdom Regulators News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kingdom Regulators. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kingdom Regulators Today - Breaking & Trending Today

EXCLUSIVE: Bittrex CEO Discusses Blockchain, DeFi And Trouble With UK Regulators - Vimarsana News

EXCLUSIVE: Bittrex CEO Discusses Blockchain, DeFi And Trouble With UK Regulators

Bittrex Global CEO Oliver Linch recently spoke with Benzinga about the transformative potential of blockchain, the UK's regulatory approach, and the rise of decentralized finance (DeFi).

EU gives green light to Microsoft's $69BILLION takeover of Activision Blizzard - Vimarsana News

EU gives green light to Microsoft's $69BILLION takeover of Activision Blizzard

The EU today approved Microsoft's $69billion takeover of Call of Duty game makers Activision Blizzard.

Rumor: Bobby Kotick 'Will Absolutely Remain' as Activision CEO If Microsoft Deal Falls Through - Vimarsana News

Rumor: Bobby Kotick 'Will Absolutely Remain' as Activision CEO If Microsoft Deal Falls Through

Following the announcement of Microsoft's proposed acquisition of Activision Blizzard, there was a report from The Wall Street [...]

SP Jain Global President Mr. Nitish Jain: We are very excited to launch SP Jain London School of Management - Vimarsana News

SP Jain Global President Mr. Nitish Jain: We are very excited to launch SP Jain London School of Management

SP Jain Global, known for its multi-city model of education has launched another campus in London, SP Jain London School of Management

UK regulators give okay to use psychedelic drug to treat depression in first clinical trial - Vimarsana News

UK regulators give okay to use psychedelic drug to treat depression in first clinical trial

NationofChange UK regulators give okay to use psychedelic drug to treat depression in first clinical trial "We think this could be a treatment for a number of depressive disorders besides major depression, including PTSD, treatment-resistant depression, obsessive-compulsive disorder, and possibly some types of substance abuse." Dimethyltriptamine, a psychedelic drug, will soon be trial-led in the United Kingdom to treat depression. UK Regulators will begin the trial by giving the “spirit molecule” drug to healthy individuals and then follow it up with a second trial on patient...